| N-ALPHA-FMOC-N-OMEGA-(2,2,4,6,7-PENTAMETHYLDIHYDRO-BENZOFURAN-5-SULFONYL)-L-ARGININE 4-BENZYLOXYBENZYL ESTER POLYMER BOUND | N-ALPHA-FMOC-N-OMEGA-(2,2,4,6,7-PENTAMETHYLDIHYDRO-BENZOFURAN-5-SULFONYL)-L-ARGININE 4-BENZYLOXYBENZYL ESTER POLYMER BOUND | |
| N-alpha-t-Butyloxycarbonyl-L-leucine p-nitrophenyl ester | N-alpha-t-Butyloxycarbonyl-L-leucine p-nitrophenyl ester | |
| N-alpha-Cbz-L-lysine | N2-[(Phenylmethoxy)carbonyl]-L-lysin | 2212-75-1 |
| Glycocholic acid | N-(3-α,7-α,12-α-Trihydroxycholan-24-oyl)glycin | 475-31-0 |
| BOC-D-Arg(Tos)-OH | BOC-D-Arg(Tos)-OH | 61315-61-5 |
| N-ALPHA-T-BOC-ETHYLMERCAPTO-L-CYSTEINE DICYCLOHEXYLAMMONIUM SALT | N-ALPHA-T-BOC-ETHYLMERCAPTO-L-CYSTEINE DICYCLOHEXYLAMMONIUM SALT | 25461-00-1 |
| N-ALPHA-TRITYL-O-BENZYL-L-HOMOSERINE DIETHYLAMINE | N-ALPHA-TRITYL-O-BENZYL-L-HOMOSERINE DIETHYLAMINE | 1272755-09-5 |
| N-ALPHA-BENZOYL-L-HISTIDINE | Nα-Benzoyl-L-histidin | 5354-94-9 |
| N(alpha)-((acetylthio)acetyl)-phenylalanyl-prolyl-arginine chloromethyl ketone | N(alpha)-((acetylthio)acetyl)-phenylalanyl-prolyl-arginine chloromethyl ketone | 115290-74-9 |
| N-ALPHA-T-BUTYLOXYCARBONYL-L-HOMOTYROSINE DICYCLOHEXYLAMINE | N-ALPHA-T-BUTYLOXYCARBONYL-L-HOMOTYROSINE DICYCLOHEXYLAMINE | |
| N-alpha-Allyloxycarbonyl-N-epsilon-(9-fluorenylmethyloxycarbonyl)-L-lysine | N-alpha-Allyloxycarbonyl-N-epsilon-(9-fluorenylmethyloxycarbonyl)-L-lysine | 186350-56-1 |
| NALPHA-TERT-BUTOXYCARBONYL-L-TERT-LEUCINE | NALPHA-TERT-BUTOXYCARBONYL-L-TERT-LEUCINE | |
| N(alpha)-(2-naphthylsulfonylglycyl)-4-oxamidinophenylalanine piperidide | N(alpha)-(2-naphthylsulfonylglycyl)-4-oxamidinophenylalanine piperidide | 117855-58-0 |
| N(alpha)-(2-naphthylsulfonylglycyl)-4-guanidinomethylphenylalaninepiperidide | N(alpha)-(2-naphthylsulfonylglycyl)-4-guanidinomethylphenylalaninepiperidide | 109273-51-0 |
| N-alpha-t-Butyloxycarbonyl-beta-(2-benzothiazolyl)-L-alanine | N-alpha-t-Butyloxycarbonyl-beta-(2-benzothiazolyl)-L-alanine | 1263045-14-2 |
| N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-in-t-butyloxycarbonyl-L-dihydrotryptophan | N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-in-t-butyloxycarbonyl-L-dihydrotryptophan | 854890-33-8 |
| N-ALPHA-TERT-BUTOXYCARBONYL-L-PHENYLGLYCINE | N-ALPHA-TERT-BUTOXYCARBONYL-L-PHENYLGLYCINE | |
| N-alpha-Boxycarbonyl-L-propargylglycine | N-alpha-Boxycarbonyl-L-propargylglycine | |
| N(alpha)-acetylglycyllysyl methyl ester | N(alpha)-acetylglycyllysyl methyl ester | 10236-44-9 |
| N(alpha)-tosylarginine-4-nitroanilide | N(alpha)-tosylarginine-4-nitroanilide | 36186-55-7 |
| NALPHA-TERT-BUTOXYCARBONYL-L-ASPARTIC ACID | NALPHA-TERT-BUTOXYCARBONYL-L-ASPARTIC ACID | |
| N-ALPHA-T-BUTYLOXYCARBONYL-L-3-IODO-TYROSINE | N-ALPHA-T-BUTYLOXYCARBONYL-L-3-IODO-TYROSINE | |
| NALPHA-TERT-BUTOXYCARBONYL-3-(2-THIENYL)-L-ALANINE | NALPHA-TERT-BUTOXYCARBONYL-3-(2-THIENYL)-L-ALANINE | |
| Name Reactions and Reagents In Organic Synthesis | Name Reactions and Reagents In Organic Synthesis | |
| N(alpha)--fluorenylmethyloxycarbonylamino-4N-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)butyric acid | N(alpha)--fluorenylmethyloxycarbonylamino-4N-(1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl)butyric acid | |
| N-ALPHA-TERT-BUTYLOXYCARBONYL-(S)-AZEPIN-2-CARBOXYLIC ACID | N-ALPHA-TERT-BUTYLOXYCARBONYL-(S)-AZEPIN-2-CARBOXYLIC ACID | |
| N-ALPHA-TERT-BUTOXYCARBONYL-D-NORLEUCINE | N-ALPHA-TERT-BUTOXYCARBONYL-D-NORLEUCINE | |
| NALPHA-TERT-BUTOXYCARBONYL-3-(4-THIAZOLYL)-D-ALANINE | NALPHA-TERT-BUTOXYCARBONYL-3-(4-THIAZOLYL)-D-ALANINE | |
| N-alpha-Methyl-L-aspartic acid -t-butyl ester hydrochloride | N-alpha-Methyl-L-aspartic acid -t-butyl ester hydrochloride | |
| N-alpha-t-Butyloxycarbonyl-N-gamma-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-L-2,3-diaminopropionic acid | N-alpha-t-Butyloxycarbonyl-N-gamma-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-L-2,3-diaminopropionic acid | |
| N-alpha-t-Butyloxycarbonyl-gamma-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-D-2,4-diaminobutyric acid | N-alpha-t-Butyloxycarbonyl-gamma-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-D-2,4-diaminobutyric acid | |
| N-alpha-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-N-gamma-(9-fluorenylmethyloxycarbonyl)-L-ornithine | N-alpha-(4,4-Dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-N-gamma-(9-fluorenylmethyloxycarbonyl)-L-ornithine | |
| N-alpha-t-Butyloxycarbonyl-N-beta-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-L-2,4-diaminobutyric acid | N-alpha-t-Butyloxycarbonyl-N-beta-[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl]-L-2,4-diaminobutyric acid | |
| N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-Lys[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-OH | N-alpha-(9-Fluorenylmethyloxycarbonyl)-D-Lys[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-OH | |
| N-alpha-t-Butoxycarbonyl-L-alpha--diaminopropionic acid -alpha-methyl ester hydrochloride (Boc-Dap-methoxy hydrochloride) | N-alpha-t-Butoxycarbonyl-L-alpha--diaminopropionic acid -alpha-methyl ester hydrochloride (Boc-Dap-methoxy hydrochloride) | |
| N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-gamma[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-ornithine | N-alpha-(9-Fluorenylmethyloxycarbonyl)-N-gamma[1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)-3-methylbutyl]-L-ornithine | |
| N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE | N-ALPHA-CBZ-GLYCINE N-METHOXY-N-METHYLAMIDE | 121505-94-0 |
| N-ALPHA-T-BUTYLOXYCARBONYL-DIPROPYLGLYCINE DICYCLOHEXYLAMINE | N-ALPHA-T-BUTYLOXYCARBONYL-DIPROPYLGLYCINE DICYCLOHEXYLAMINE | |
| N-ALPHA-TRITYL-D-HOMOSERINE DIETHYLAMMONIUM SALT | N-ALPHA-TRITYL-D-HOMOSERINE DIETHYLAMMONIUM SALT | |
| N-ALPHA-T-BUTYLOXYCABONYL-N-ALPHA-METHYL-L-ISOLEUCINE | N-ALPHA-T-BUTYLOXYCABONYL-N-ALPHA-METHYL-L-ISOLEUCINE | |
| N-alpha-Cbz-D-2-4-diaminobutanoic acid | N-alpha-Cbz-D-2-4-diaminobutanoic acid | 70882-66-5 |
| Fmoc-Asn(Trt)-OH | Fmoc-Asn(Trt)-OH | 132388-59-1 |
| N(alpha)-dansyl-N(omega)-1,N(6)-etheno-ADP-ribosylarginine methyl ester | N(alpha)-dansyl-N(omega)-1,N(6)-etheno-ADP-ribosylarginine methyl ester | 104257-22-9 |
| 3-(3-(N-(alpha-methylbenzyl)aminomethyl)pyrrolidiny)-5-((2-oxooxazolidinyl)methyl)indole | 3-(3-(N-(alpha-methylbenzyl)aminomethyl)pyrrolidiny)-5-((2-oxooxazolidinyl)methyl)indole | |
| N(alpha)-acetyl-epsilon-(2-propenal)lysine | N(alpha)-acetyl-epsilon-(2-propenal)lysine | 99124-74-0 |
| 3-(N-alpha-methylbenzyl)aminomethyl-1-(2-(5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl)ethyl)pyrrolidine | 3-(N-alpha-methylbenzyl)aminomethyl-1-(2-(5-(2-oxo-1,3-oxazolidin-4-ylmethyl)-1H-indol-3-yl)ethyl)pyrrolidine | |
| N-ALPHA-TERT-BUTOXYCARBONYL-L-PROLINOL | N-ALPHA-TERT-BUTOXYCARBONYL-L-PROLINOL | |
| NALPHA-9-Fluorenylmethoxycarbonyl-L-pipecolinic acid | NALPHA-9-Fluorenylmethoxycarbonyl-L-pipecolinic acid | 84000-01-1 |
| N-(A-METHYL-4-NITROBENZYLIDENE)BENZYLAMINE | N-(A-METHYL-4-NITROBENZYLIDENE)BENZYLAMINE | |
| N(a)-Methylhistamine, DiHCl | N(a)-Methylhistamine, DiHCl | |
| N-[A-METHYL-4-(METHYLSULPHONYL)BENZYL]-N-(TETRAHYDROFURFURYL)BENZAMIDE | N-[A-METHYL-4-(METHYLSULPHONYL)BENZYL]-N-(TETRAHYDROFURFURYL)BENZAMIDE | |
| N-(A-METHYLBENZYL)-1-AMINOBENZOTRIAZOLE | N-(A-METHYLBENZYL)-1-AMINOBENZOTRIAZOLE | 105026-59-3 |
| N-(A-METHYLBENZYLIDENE)ISOPROPYLAMINE | N-(A-METHYLBENZYLIDENE)ISOPROPYLAMINE | 6907-73-9 |
| 6α-Naloxol Hydrochloride | 6α-Naloxol Hydrochloride | 34520-00-8 |
| Naloxone-d5 3-β-D-Glucuronide | Naloxone-d5 3-β-D-Glucuronide | |
| Naloxone-3-sulfate Sodium Salt | Naloxone-3-sulfate Sodium Salt | 156047-22-2 |
| 6β-Naloxol-d5 Hydrochloride | 6β-Naloxol-d5 Hydrochloride | |
| Naloxone 2,3,4-Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester | Naloxone 2,3,4-Tri-O-acetyl-β-D-glucuronic Acid Methyl Ester | |
| Naloxol 6-b-D-glucuronide | Naloxol 6-b-D-glucuronide | |
| Naloxegol | Naloxegol | 854601-70-0 |
| Naloxone N-Oxide | Naloxone N-Oxide | 112242-14-5 |
| NALOXOL-3-GLUCURONIDE | NALOXOL-3-GLUCURONIDE | 24326-39-4 |
| Naloxone | Naloxon | 465-65-6 |
| NALOXONE-D5 | NALOXONE-D5 | 1261079-38-2 |
| NALOXONE-3-GLUCURONIDE | NALOXONE-3-GLUCURONIDE | |
| Naloxone-3,14-diacetate | Naloxone-3,14-diacetate | 50510-01-5 |
| Naloxol 6--D-Glucuronide | Naloxol 6--D-Glucuronide | |
| NALOXONE METHIODIDE | NALOXONE METHIODIDE | 93302-47-7 |
| Naloxone-d5 3-Methyl Ether | Naloxone-d5 3-Methyl Ether | 1261082-21-6 |
| NALOXONE, [N-ALLYL 2,3-3H] | NALOXONE, [N-ALLYL 2,3-3H] | |
| NALOXONE HYDROCHLORIDE DIHYDRATE MM(CRM STANDARD) | NALOXONE HYDROCHLORIDE DIHYDRATE MM(CRM STANDARD) | |
| NALOXONE IMPURITY A4,5-ALPHA-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE (NOROXYMORPHONE) EPN(CRM STANDARD) | NALOXONE IMPURITY A4,5-ALPHA-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE (NOROXYMORPHONE) EPN(CRM STANDARD) | |
| NALP1 (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7) (A)
| NALP1 (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7) (A)
| |
| Naloxone 3-b-D-Glucuronide | Naloxone 3-b-D-Glucuronide | 22135-79-1 |
| NALOXONE HYDROCHLORIDE BP STANDARD(CRM STANDARD) | NALOXONE HYDROCHLORIDE BP STANDARD(CRM STANDARD) | |
| NALOXONE HYDROCHLORIDE ASSAY STANDARD BP(CRM STANDARD) | NALOXONE HYDROCHLORIDE ASSAY STANDARD BP(CRM STANDARD) | |
| NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1) (A)
| NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1) (A)
| |
| NALOXONE HYDROCHLORIDE EPN(CRM STANDARD) | NALOXONE HYDROCHLORIDE EPN(CRM STANDARD) | |
| NALOXONE MM(CRM STANDARD) | NALOXONE MM(CRM STANDARD) | |
| NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1)
| NALP3 (NACHT-, LRR- and PYD-Containing Protein 3, Cryopyrin, Cold Autoinflammatory Syndrome 1 Protein, PYPAF1, PYRIN-Containing APAF1-like Protein 1, CIAS1)
| |
| naloxone-6-spirohydantoin | naloxone-6-spirohydantoin | 87872-71-7 |
| naloxone receptor | naloxone receptor | |
| naloxazone | naloxazone | 73674-85-8 |
| naloxazine | naloxazine | 71786-91-9 |
| NALOXONAZINE DIHYDROCHLORIDE | NALOXONAZINE DIHYDROCHLORIDE | 82824-01-9 |
| NALP1, NT (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7)
| NALP1, NT (NACHT-, LRR- and PYD-Containing Protein 1, DEFCAP, NAC, CARD7, Caspase Recruitment Domain 7)
| |
| NALOXONE BENZOYLHYDRAZONE | NALOXONE BENZOYLHYDRAZONE | 119630-94-3 |
| NALOXONE USP(CRM STANDARD) | NALOXONE USP(CRM STANDARD) | |
| naloxone-3-O-methyl-oxime | naloxone-3-O-methyl-oxime | |
| NALOXONE FLUORESCEIN | NALOXONE FLUORESCEIN | 88641-41-2 |
| NALOXONE BENZOYLHYDRAZONE | NALOXONE BENZOYLHYDRAZONE | |
| Naloxone hydrochloride dihydrate | Naloxone hydrochloride dihydrate | 51481-60-8 |
| Naloxone hydrochloride | (5α)-17-Allyl-4,5-epoxy-3,14-dihydroxymorphinan-6-onhydrochlorid | 357-08-4 |
| Naloxyindole | Naloxyindole | 126580-45-8 |
| Naloxone methylbromide | Naloxone methylbromide | |
| NALP1 protein | NALP1 protein | |
| NB.BPU10I | NB.BPU10I | |
| NBC1 (HCO3 Cotransporters 1, pNBC) A
| NBC1 (HCO3 Cotransporters 1, pNBC) A
| |
| NBC1 (HCO3 Cotransporters 1)
| NBC1 (HCO3 Cotransporters 1)
| |
| NBC3 (HCO3 Cotransporters 3) C
| NBC3 (HCO3 Cotransporters 3) C
| |